BACKGROUND: Living kidney donors in the United States who were obese at donation are at increased risk of end-stage renal disease and may benefit from intensive postdonation follow-up. However, they are less likely to have complete follow-up data. Center variation and risk factors for incomplete follow-up are unknown. METHODS: Adult living kidney donors with obesity (body mass index, ≥30 kg/m) at donation reported to the Scientific Registry of Transplant Recipients from January 2005 to July 2015 were included (n = 13 831). Donor characteristics were compared by recorded serum creatinine at 6 months postdonation, and multilevel logistic regression models were used to estimate odds of 6-month creatinine. RESULTS: After adjustment, older age, female sex, and donation after implementation of new center follow-up requirements were associated with higher odds of 6-month creatinine, with lower odds for obese donors with a history of smoking, biologically related donors, and at centers with higher total living donor volume. 23% of variation in recorded 6-month serum creatinine among obese donors was attributed to center (intraclass correlation coefficient: 0.232, P < 0.001). The adjusted probability of 6-month creatinine by center ranged from 10% to 91.5%. CONCLUSIONS: Tremendous variation in recorded 6-month postdonation serum creatinine exists among obese living donors, with high volume centers having the lowest probability of follow-up. Moreover, individual-level characteristics such as age, sex, and relationship to recipient were associated with recorded 6-month creatinine. Given increased risk for end-stage renal disease among obese living donors, center-level efforts targeted specifically at increasing postdonation follow-up among obese donors should be developed and implemented.
BACKGROUND: Living kidney donors in the United States who were obese at donation are at increased risk of end-stage renal disease and may benefit from intensive postdonation follow-up. However, they are less likely to have complete follow-up data. Center variation and risk factors for incomplete follow-up are unknown. METHODS: Adult living kidney donors with obesity (body mass index, ≥30 kg/m) at donation reported to the Scientific Registry of Transplant Recipients from January 2005 to July 2015 were included (n = 13 831). Donor characteristics were compared by recorded serum creatinine at 6 months postdonation, and multilevel logistic regression models were used to estimate odds of 6-month creatinine. RESULTS: After adjustment, older age, female sex, and donation after implementation of new center follow-up requirements were associated with higher odds of 6-month creatinine, with lower odds for obese donors with a history of smoking, biologically related donors, and at centers with higher total living donor volume. 23% of variation in recorded 6-month serum creatinine among obese donors was attributed to center (intraclass correlation coefficient: 0.232, P < 0.001). The adjusted probability of 6-month creatinine by center ranged from 10% to 91.5%. CONCLUSIONS: Tremendous variation in recorded 6-month postdonation serum creatinine exists among obese living donors, with high volume centers having the lowest probability of follow-up. Moreover, individual-level characteristics such as age, sex, and relationship to recipient were associated with recorded 6-month creatinine. Given increased risk for end-stage renal disease among obese living donors, center-level efforts targeted specifically at increasing postdonation follow-up among obese donors should be developed and implemented.
Authors: Didier A Mandelbrot; Martha Pavlakis; Seth J Karp; Scott R Johnson; Douglass W Hanto; James R Rodrigue Journal: Transplantation Date: 2009-10-15 Impact factor: 4.939
Authors: Amy D Waterman; Mary Amanda Dew; Connie L Davis; Melanie McCabe; Jennifer L Wainright; Cynthia L Forland; Lee Bolton; Matthew Cooper Journal: Transplantation Date: 2013-03-27 Impact factor: 4.939
Authors: Mary E Cox; William S Yancy; Cynthia J Coffman; Truls Ostbye; James A Tulsky; Stewart C Alexander; Rebecca J Namenek Brouwer; Rowena J Dolor; Kathryn I Pollak Journal: Patient Educ Couns Date: 2011-02-12
Authors: Hassan N Ibrahim; Robert Foley; LiPing Tan; Tyson Rogers; Robert F Bailey; Hongfei Guo; Cynthia R Gross; Arthur J Matas Journal: N Engl J Med Date: 2009-01-29 Impact factor: 91.245
Authors: Mary Margaret Huizinga; Lisa A Cooper; Sara N Bleich; Jeanne M Clark; Mary Catherine Beach Journal: J Gen Intern Med Date: 2009-09-18 Impact factor: 5.128
Authors: S J Taler; E E Messersmith; A B Leichtman; B W Gillespie; C E Kew; M D Stegall; R M Merion; A J Matas; H N Ibrahim Journal: Am J Transplant Date: 2012-11-08 Impact factor: 8.086
Authors: Babak J Orandi; Rhiannon D Reed; Haiyan Qu; Grace Owens; Sydney Brooks; A Cozette Killian; Vineeta Kumar; Saulat S Sheikh; Robert M Cannon; Douglas J Anderson; Cora E Lewis; Jayme E Locke Journal: Clin Transplant Date: 2022-02-27 Impact factor: 3.456